title: Effects of TNF-α inhibitors upon the mechanisms of action of VEGF.
authors: Giuseppe
authors: G
authors: Murdaca
authors: Francesca
authors: F
authors: Spanò
authors: Maurizio
authors: M
authors: Miglino
authors: Francesco
authors: F
authors: Puppo
mesh_terms: D000068879:Adalimumab; D020533:Angiogenesis Inhibitors / Q000276:immunology / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D009389:Neovascularization, Pathologic / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology / Q000378:metabolism*
chemical_list: D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D000069285:Infliximab; D000068879:Adalimumab